1-7 of 7
Corinne Hedgley
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Spirit 2: Final 5 Year Analysis of the UK National Cancer Research Institute Randomized Study Comparing Imatinib with Dasatinib in Patients with Newly Diagnosed Chronic Phase CML

Stephen O'Brien, MBBS, BSc, PhD MRCPath, MRCP, Leanne Cork, BSc, Valeria Bandeira, MD, Ruth Bescoby, MSc, Letizia Foroni, MD PhD, Lynn Alaily, MSc, RN, NDN, MICR, Wendy Osborne, MBBS, Helen Bell-Gorrod, BSc, Nicholas Latimer, PhD, Jane Apperley, MB ChB MD, Corinne Hedgley, BSc (Hons), Richard Syzdlo, PhD, Jennifer Byrne, MB, ChB, MRCP, MRCPath, MD, Christopher Pocock, MD PhD, Bernard Ramsahoye, MB, ChB, PhD FRCPath, MRCP, Thomas Zwingers, BSc, James Wason, PhD, Mhairi Copland, PhD MBBChir, FRCP, FRCPath, Richard Clark, MBBS, MRCP, MRCPath, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 457.
https://doi.org/10.1182/blood-2018-99-110128
Published: 2018
Journal Articles

Spirit 2: An NCRI Randomised Study Comparing Dasatinib with Imatinib in Patients with Newly Diagnosed CML

Stephen G O'Brien, BSc (Hons) PhD MBChB FRCP MRCPath, Corinne Hedgley, BSc, Sarah Adams, BSc MSc, Letizia Foroni, MDPhD, Jane F. Apperley, MD, Tessa L Holyoake, MDPhDFRSE FMedSci, Christopher Pocock, MD PhD, Jenny L Byrne, MB ChB PhDFRCP FRCPath, Lynn Margaret Seeley, MSc RN NDN, Wendy L Osborne, MBBS(Hons) MRCP FRCPath, John M Goldman, DM, Mhairi Copland, BSc PhDFRCP FRCPath, Richard E Clark, MA, MD
Journal: Blood
Blood (2014) 124 (21): 517.
https://doi.org/10.1182/blood.V124.21.517.517
Published: 2014
Journal Articles

A Novel Splice Site Variant of hOCT-1 and Response to Imatinib.

Jacob Grinfeld, Juan M Alonso-Dominguez, Mary Alikian, Mikel Valgañón, PhD, Georgios Nteliopoulos, PhD, Deborah L. White, PhD, FFSc(RCPA), David Marin, Corinne Hedgley, Stephen O'Brien, Richard E. Clark, MD, Richard M Szydlo, Jane Apperley, John M Goldman, MD, Letizia Foroni, Gareth Gerrard, PhD
Journal: Blood
Blood (2012) 120 (21): 2555.
https://doi.org/10.1182/blood.V120.21.2555.2555
Published: 2012
Journal Articles

PTCH1 Expression At Diagnosis Reliably Predicts Treatment Failure in Imatinib-Treated Chronic Myeloid Leukaemia Patients

Juan M. Alonso-Dominguez, Sr., MD, Jacob Grinfeld, MD, Mary Alikian, David Marin, Alistair Reid, PhD, Mustafa Daghistani, Jane Apperley, John M Goldman, MD, Corinne Hedgley, Steve O‘Brien, Richard E. Clark, MD, Letizia Foroni, Gareth Gerrard, PhD
Journal: Blood
Blood (2012) 120 (21): 875.
https://doi.org/10.1182/blood.V120.21.875.875
Published: 2012
Journal Articles

Dasatinib may overcome the negative prognostic impact of KIR2DS1 in newly diagnosed patients with chronic myeloid leukemia

Sara Ali, Ruhena Sergeant, Stephen G. O'Brien, Letizia Foroni, Corinne Hedgley, Gareth Gerrard, Dragana Milojkovic, Kate Stringaris, Ahmad Khoder, Abdullah Alsuliman, Maria Gilleece, Ian H. Gabriel, Nichola Cooper, John M. Goldman, Jane F. Apperley, Richard E. Clark, David Marin, Katayoun Rezvani
Journal: Blood
Blood (2012) 120 (3): 697–698.
https://doi.org/10.1182/blood-2012-04-421016
Published: 2012
Journal Articles

Predictive value of early molecular response in patients with chronic myeloid leukemia treated with first-line dasatinib

Brief Report
David Marin, Corinne Hedgley, Richard E. Clark, Jane Apperley, Letizia Foroni, Dragana Milojkovic, Christopher Pocock, John M. Goldman, Stephen O'Brien
Journal: Blood
Blood (2012) 120 (2): 291–294.
https://doi.org/10.1182/blood-2012-01-407486
Published: 2012
Journal Articles

The Predictive Value of Early Molecular Response in Chronic Phase CML Patients Treated with Dasatinib First Line Therapy

David Marin, Corinne Hedgley, Richard E Clark, Jane F Apperley, MBChB, MD, FRCP, FRCPath, Letizia Foroni, MD PhD, Dragana Milojkovic, MD, Christopher Pocock, John M Goldman, Stephen O'Brien
Journal: Blood
Blood (2011) 118 (21): 785.
https://doi.org/10.1182/blood.V118.21.785.785
Published: 2011